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ART I CL E
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Circulating murine monocytes comprise two largely exclusive subpopulations that are
responsible for seeding normal tissues (Gr-1/CCR2/CX3CR1high) or responding to sites of
inflammation (Gr-1/CCR2/CX3CR1lo). Gr-1 monocytes are recruited to the site of
infection during the early stages of immune response to the intracellular pathogen
Toxoplasma gondii. A murine model of toxoplasmosis was thus used to examine the
importance of Gr-1 monocytes in the control of disseminated parasitic infection in vivo.
The recruitment of Gr-1 monocytes was intimately associated with the ability to suppress
early parasite replication at the site of inoculation. Infection of CCR2/ and MCP-1/
mice with typically nonlethal, low doses of T. gondii resulted in the abrogated recruitment
of Gr-1 monocytes. The failure to recruit Gr-1 monocytes resulted in greatly enhanced
mortality despite the induction of normal Th1 cell responses leading to high levels of IL-12,
TNF-, and IFN-. The profound susceptibility of CCR2/ mice establishes Gr-1
monocytes as necessary effector cells in the resistance to acute toxoplasmosis and suggests
that the CCR2-dependent recruitment of Gr-1 monocytes may be an important general
mechanism for resistance to intracellular pathogens.

CORRESPONDENCE
L. David Sibley:
sibley@borcim.wustl.edu
Abbreviations used: BMM, BMderived macrophages; CNS,
central nervous system; Tip-DC,
TNF/inducible nitric oxide
synthase–producing DC.

Monocytes recruited to the site of an infection
potentially bring critical contributions to the
immune control of foreign invaders. On arrival,
they may differentiate into macrophages that
act as effectors or into DCs that efficiently ignite the adaptive immune response (1). Markers
for human monocyte subpopulations were described more than a decade ago (2), but markers
for corresponding murine subsets have been
identified only recently. Circulating murine
monocytes comprise two distinct subpopulations
that serve very different roles (3). Although
Gr-1/CCR2/CX3CR1high monocytes seed
normal tissues, their counterparts (Gr-1/
CCR2/CX3CR1lo) represent “inflammatory”
monocytes that home to sites of inflammation
(3–5). Comparable subsets that exist in humans
are known as CD16/CX3CR1high/CCR2 and
CD14/CX3CR1lo/CCR2, although their precise roles are less well delineated (3).
Gr-1 monocytes express the CCR2 chemokine receptor and respond primarily to the
ligand MCP-1 (CCL2), as well as MCP-3
(CCL7) and MCP-5 (CCL12; references 6, 7).
W.A. Kuziel’s present address is Autoimmunne and Inflammatory
Diseases, Protein Design Laboratories, Inc., Fremont, CA 94555.
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MCP-1 is produced by a variety of cells in response to inflammation and plays a critical role
in the recruitment of monocytes (8). CCR2/
mice have profound defects in monocyte recruitment though constitutive trafficking remains
unaffected, which makes it possible to dissect the
role of monocyte recruitment during inflammation (9). Recently, a unique population of TNF/
inducible nitric oxide synthase–producing (Tip)–
DCs was found to be absent from the spleens
of CCR2/ mice during infection with Listeria
monocytogenes (10). Tip-DCs are CCR2 and
contribute to the early control of L. monocytogenes, which suggests that the recruitment of
monocytes via CCR2 plays a role in the early
control of infection with other intracellular
pathogens.
The resistance to an acute challenge with a
Toxoplasma gondii infection in a mouse requires
the rapid induction of a robust Th1 cell–polarized cell-mediated immune response that leads
to the curtailment of early parasite replication
(11). Resistance to both the acute and chronic
stages of infection with T. gondii hinges primarily on a high level production of IFN- (12,
13). Consistent with this requirement, IL-12/
(14, 15), IFN-/ (16), and IFN-R/
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mice (13) have all been shown to be extremely susceptible to
acute toxoplasmosis and rapidly succumb to a challenge with
nonvirulent T. gondii strains that are nonlethal in normal
mice. Toxoplasma is able to invade and replicate in a wide variety of cell types, including professional phagocytes, and
IFN- responsiveness in both hematopoietic and nonhematopoietic cell lineages is important for resistance (13).
The functions of neutrophils (17–19) and CD8
splenic DCs (20–22) in the production of IL-12 in early responses to infection with T. gondii have been documented in
previous studies. Macrophages cultured in vitro also produce
IL-12 when challenged with T. gondii (23); however, it is
uncertain as to what extent this response is important in
vivo. Although the early induction of cytokines is a key mediator of resistance to infection, it is less clear if phagocytic cells
also play important effector roles in the control of acute toxoplasmosis. A prominent feature of nonlethal infections in
mice initiated with low doses of a nonvirulent strain of T.
gondii is the early predominance of Gr-1 macrophages at
the site of infection (24). We have previously shown that
these Gr-1 monocytes produce inducible nitric oxide synthase, secrete IL-12, and are able to inhibit parasite growth
when challenged in vitro (24), all of which suggest that they
contribute in vivo to the control of parasite replication.
To determine the role of inflammatory monocytes in the
control of toxoplasmosis, we examined the response to infections in MCP-1/ and CCR2/ mice in which monocyte
recruitment is selectively impaired. Our results demonstrate
an essential, nonredundant requirement for CCR2 and a
substantial role for MCP-1 in the recruitment of Gr-1 inflammatory monocytes. We also find that Gr-1 monocytes
are essential for the local control of parasite replication,
which indicates that monocytes play a major effector role in
the resistance to toxoplasmosis.
RESULTS
Parasites are a potent stimulus for chemokine induction
Previous experiments have demonstrated a profound influx
of CD68/Gr-1 macrophages during i.p. infection with T.
gondii (24). To identify chemokines that might contribute to
monocyte recruitment to the site of infection, we examined
the expression of chemokines by RNase protection assay after
the low-dose infection of mice (Fig. 1 A). Peritoneal exudate
cells from T. gondii–infected mice displayed substantially increased mRNA levels for several of the chemokine genes
assayed when compared with peritoneal exudate cells from
mock-infected mice. Specifically, MCP-1 (CCL2), MIP-1
(CCL4), and lymphotactin (XCL1) mRNA levels were all
observed to be increased by 70-fold (Fig. 1 B), and less
substantial increases in the mRNA levels were observed for
RANTES, MIP-1, and MIP-2.
The increase in MCP-1 mRNA levels after infection was
intriguing in light of the primary role that MCP-1 has been
shown to play in the recruitment of monocytes/macrophages
to inflammation sites (4, 8). We examined the production of
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Figure 1. Chemokines are up-regulated in response to an infection
with a nonlethal challenge of T. gondii. (A) Peritoneal cells were collected
72 h after i.p. inoculation of mice with 102 T. gondii (Tg) or media diluent
(mock). Harvested total RNA was subjected to RNase protection assay for
the indicated chemokine genes. (B) Relative levels of expression during
infection for chemokine genes assayed when compared with a mock infection control were determined by phosphor image analysis. Data shown are
representative of two independent experiments with similar results.

MCP-1 in response to an infection by measuring its concentration in peritoneal lavage fluid (Fig. 2 A) over the course of
the first 5 d after infection and the i.p. inoculation of 100
parasites. The MCP-1 concentration in peritoneal exudates
was observed to increase beginning on day 3, with the first
significant (P  0.01) increase in MCP-1 concentration
measured at day 4 after infection. The concentration was observed to subsequently decline.
MCP-1 could be produced by resident cells or by influxing proinflammatory monocytes. Therefore, we evaluated the
potential for these subpopulations to produce MCP-1. Naive
bone marrow–derived macrophages (BMM), resident peritoneal macrophages, or thioglycolate-elicited inflammatory
macrophages were challenged in vitro with live T. gondii, and
MCP-1 production was measured by performing ELISA on
samples of supernatant culture media collected after 24 h. We
found that all cell types tested, including naive BMM and resident tissue macrophages, produced MCP-1 in response to a
T. gondii infection. Thioglycolate-elicited inflammatory macrophages generated significantly higher MCP-1 concentrations (P  0.05) than resident peritoneal macrophages, which
suggests that cells residing in the peritoneum release MCP-1
in response to an infectious challenge, and influxing cells (possibly migrating in response to the early, low levels of MCP-1)
further amplify the recruitment signal on their arrival.
MCP-1 and CCR2 are essential for resistance to
acute toxoplasmosis
To examine the functional consequences of the high-level
induction of MCP-1, we challenged MCP-1/, CCR2/,
and wild-type C57BL/6J mice with doses of T. gondii that
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Figure 4. Recruitment of inflammatory monocytes (Gr-1 /CD68)
is abrogated in CCR2/ mice, but less so in MCP-1/ mice. Peritoneal
cells from (A) wild-type C57BL/6J (WT), (B) MCP-1/, and (C) CCR2/ mice
were harvested 4 d after i.p. inoculation of a dose of 102 T. gondii and analyzed
by flow cytometry. Results shown are representative of individual mice.
Numbers represent the percentage of gated cells present within the quadrant.
The experiment was repeated twice with similar results, using a total of six
mice per genotype.

Figure 2. Kinetics of MCP-1 release in peritoneum. (A) C57BL/6J
mice were i.p. infected with 102 parasites of T. gondii. The concentration of
MCP-1 present in peritoneal lavage fluid was determined by ELISA at the
times indicated after infection (*, significantly different from mock infection; P  0.01). (B) Naive BMM, resident peritoneal macrophages, or
thioglycolate (TG)-elicited macrophages were challenged in vitro with live
parasites (1:1, cells/parasites). MCP-1 concentrations in supernatant media
following 24 h of infection were determined by ELISA (*, significantly
different from resident peritoneal macrophages; P  0.05). Data shown
are means  SE for two independent experiments (using data from three
individual mice per time point in A).

are normally nonlethal (Fig. 3). In contrast to wild-type
background control mice, which demonstrated high levels of
survival at either dose (100% survival at 102 parasites and
80% survival at 103 parasites), both strains of knockout mice
displayed a lack of resistance to the acute stage of toxoplasmosis. CCR2/ mice were profoundly susceptible to acute
toxoplasmosis (a dose of 103 parasites was uniformly lethal).
Even the lowest dose, 102 parasites, resulted in 90% mortal-

ity with 80% of infected mice succumbing by day 15 after
infection. MCP-1/ mice were also more susceptible than
wild-type control mice at both inoculum levels tested. Although 90% of MCP-1/ mice survived a challenge with
102 parasites (compared with 100% survival for wild-type
C57BL/6J mice), a challenge with 103 parasites resulted in
50% mortality for MCP-1/ mice (20% mortality for the
wild type). Disease progression in MCP-1/ mice appeared
qualitatively different from CCR2/ mice; mice succumbed at later time points after infection, and some mice
displayed signs of neurological abnormality (altered gait or
loss of balance) before death at these later time points.
Failure to recruit inflammatory monocytes/macrophages to
the site of infection
We next wanted to evaluate the necessity of MCP-1 and
CCR2 for the recruitment of inflammatory monocytes/
macrophages to the peritoneum during the early stages of infection. We used FACS analysis to examine the percentage
of Gr-1/CD68 cells in the peritoneum of MCP-1/,
CCR2/, and wild-type C57BL/6J mice (Fig. 4). On day
4 after infection (i.p.) with 102 T. gondii, CCR2/ mice
were found to have significantly (P  0.05) decreased numbers of Gr-1/CD68 cells present in the peritoneum (Fig.
4 and Table I). MCP-1/ mice also failed to recruit wildtype levels of inflammatory monocytes/macrophages. However, on average they suffered a less severe recruitment defect than CCR2/ mice (Fig. 4 and Table I).

Table I. Percentage representation of peritoneal populations
Mouse genotype
Population
Gr-1/CD68
CCR2/

MCP-1/

Figure 3. Survival of
and
mice after infection
with T. gondii. Female CCR2/, MCP-1/, and wild-type C57BL/6J (WT)
mice were infected i.p. with doses of 10 2 and 103 tachyzoites, and their
survival was monitored for 30 d. Data are expressed as a cumulative
percentage of two experiments (four to five mice per group).
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CD68
Gr-1

C57BL/6J

MCP-1/

CCR2/

%a

%

%b

28.3  2.7
11.9  2.8
4.0  0.6

22.8  5.5
5.3  6.0
5.1  0.5

7.6  0.1
8.1  1.2
4.7  0.7

Percentages were determined by FACS analysis on day 4 after infection.
aData are means  SE from two experiments (n
6 mice).
bSignificantly different from other genotypes (P  0.05).
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Figure 5. CCR2/ and MCP-1/ mice produce high levels of IFN-.
Peritoneal lavage fluid and serum were collected on days 4, 7, and 10 after
infection from C57BL/6J (WT), MCP-1/, and CCR2/ mice that had received

a dose of 102 T. gondii (i.p.). Concentrations of IL-12p70, IFN-, TNF-, and
IL-4 were determined by ELISA. Data shown are means  SE from two independent experiments (n 3 individual mice per genotype) at each time point.

IFN- production is essentially normal in CCR2/
and MCP-1/ mice
We analyzed the pattern of cytokine production in response
to a T. gondii infection in MCP-1/, CCR2/, and wildtype C57BL/6J mice by measuring the concentrations of cytokines in the peritoneal exudate and serum (Fig. 5) at 4, 7,
and 10 d after mice were infected (i.p.) with 102 T. gondii. Interestingly, for the cytokines measured (IL-4, TNF-, IL12p70, and IFN-), MCP-1/ and CCR2/ mice were
capable of generating concentrations comparable to those
produced by wild-type C57BL/6J mice at all time points analyzed. Similarly, although the knockout strains of mice generated lower serum concentrations of IL-12p70 at days 4 and 7
after infection, the only concentration found to be significantly lower than wild-type levels (P  0.05) was the serum
level of IL-12p70 in CCR2/ mice at day 7 after infection.
Moreover, no significant deviation from wild-type levels in
the serum concentration of IFN-, TNF-, or IL-4 of MCP1/ and CCR2/ mice was identified at any of the time
points analyzed, which indicates that the difference in serum
IL-12p70 concentration in CCR2/ mice at day 7 does not
result in the systemic underproduction of IFN-. Splenocytes
harvested from infected CCR2/ and MCP-1/ mice
(days 7 and 10) and stimulated with low concentrations (5
g/ml) of soluble Toxoplasma Ag produced more IFN- than
splenocytes from infected wild-type C57BL/6J mice (unpublished data). This further indicates that the CCR2/ and
MCP-1/ mice are competent producers of IFN-.

were found in the peritoneal contents of CCR2/ mice
(Fig. 6). CCR2/ mice were found to have a more profound defect in their ability to suppress parasite numbers
than MCP-1/ mice. This result was also confirmed by
real-time PCR assays (unpublished data).

Control of parasite numbers
The lack of resistance to acute toxoplasmosis by mice possessing a targeted deletion of a necessary immune response
component is typically accompanied by the failure to control
replication of the parasite (e.g., IFN-/ and LRG-47/
mice). To determine if a similar phenotype was observed in
mice in which monocyte recruitment was impaired, parasites
present in the peritoneal exudate of infected MCP-1/,
CCR2/, and wild-type C57BL/6J mice were enumerated
by plaque assay. Considerably greater numbers of parasites
1764

Neuropathology in MCP-1/ mice
To explore the possibility that MCP-1/ mice, which perish
at later time points (day 19–30 after infection), succumb to
neuropathology, we examined sections of brain tissue from infected MCP-1/ and wild-type C57BL/6J mice in a blinded
fashion. The pathological features observed were characteristic
of a T. gondii infection, with three distinguishable grades of severity present in the brain tissues examined. The least severe
pattern of pathology found (Fig. 7 B) was a multifocal meningoencephalitis with minimal perivascular cuffing or neuronal
degeneration. The intermediate grade of severity (Fig. 7 C)
manifested as a diffuse meningoencephalitis and occasionally
noted neuronal degeneration. The most severe grade (Fig. 7

Figure 6. CCR2/ and MCP-1/ mice fail to control early parasite replication, allowing systemic dissemination. CCR2/, MCP-1/,
and wild-type C57BL/6J mice were i.p. infected with a dose of 10 2 T. gondii.
Parasites were enumerated by performing plaque assays using recovered
intraperitoneal contents at the indicated times after infection. Data shown
are means  SD (from two mice per genotype) from a representative experiment of two with highly similar outcomes (*, significantly different
from WT; P  0.05).
MONOCYTES CONTROL ACUTE TOXOPLASMOSIS | Robben et al.
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Table II. MCP-1/ mice suffer more severe neuropathology
Pathological severity gradea
Genotype

()

()

()

MCP-1/b

4c

C57BL/6J

5

10
15

6
0

Sections were assigned a severity grade in a blind fashion. Data represent five
nonserial sections per mouse and four mice per genotype.
aDistinguishing characteristics of severity grades are as follows: least severe (),
multifocal meningoencephalitis with minimal perivascular cuffing; intermediate
(), diffuse meningoencephalitis with more extensive perivascular cuffing; and
most severe (), diffuse meningoencephalitis with cuffing the same as in (),
with necrotic foci, and loss of parenchyma.
bSignificantly more likely to be found to have more severe pathology (Mann-Whitney
U test; P  0.05).
cNumber of sections assigned to designated grade.

Figure 7. Patterns of CNS inflammation observed during T. gondii
infection in MCP-1/ mice. (A–D) Hematoxylin and eosin–stained sections from brains harvested at day 35 after infection from MCP-1 / and
wild-type C57BL/6J mice infected i.p. with a dose of 10 2 T. gondii were
examined and graded for the severity of inflammation in a blinded fashion.
Representative images of the different grades of neuropathology that
were observed. (A) Normal control (uninfected); (B) least severe ();
(C) intermediate (); and (D) most severe () are shown. (E) Example
of encephalitis and meningitis with the infiltration of mononuclear cells.
(F) Enlarged region of the meninges showing infiltration and perivascular
infiltration of mononuclear cells. Similar pathology was found in a second
experiment. Bars: (A–D and F) 5 m; (E) 20 m.

D) was assigned to sections that displayed one or more foci of
necrosis and a marked loss of parenchyma in addition to the
features of the intermediate grade. The composite severity
score of independently examined sections revealed that sections from MCP-1/ mice were significantly more likely
(P  0.05) to display a more severe grade of pathology (Table
II). In mice with intermediate or severe grade inflammation,
encephalitis was accompanied by meningitis and perivascular
infiltration of mononuclear cells (Fig. 7, E and F).
DISCUSSION
Resistance to acute toxoplasmosis in the mouse model is associated with the ability to suppress parasite replication
through a variety of IFN-–dependent static and cidal mechanisms (11). Effective control requires the early production of
IL-12 that may be produced by neutrophils (19, 25, 26), DCs
(21), or macrophages (23). Because Gr-1/CD68 macrophages are the predominant myeloid population found in the
peritoneum early after infection with a nonvirulent strain of
JEM VOL. 201, June 6, 2005

T. gondii (24), we examined their recruitment during the
early stages of infection with T. gondii. The contribution of
Gr-1 monocytes was delineated by examining infections in
mice lacking the major ligand and receptor involved in inflammatory monocyte recruitment. CCR2/ and MCP-1/
mice were found to be extremely susceptible to acute toxoplasmosis and were unable to survive typically nonlethal doses
of a nonvirulent strain of T. gondii. Increased susceptibility of
CCR2/ or MCP-1/ mice occurred despite the induction of normally high levels of Th1 cell cytokines, which indicates that in the absence of recruitment of Gr-1 monocyte
cells, these cytokines are not able to control infection. Our
results identify an essential requirement for CCR2, as well as
a contributory role for MCP-1, in the recruitment of Gr-1
monocytes during infection, and they document an important in vivo role for Gr-1 monocytes as effector cells in resistance to acute toxoplasmosis.
T. gondii is capable of infecting a wide range of cell types
in vivo, including professional phagocytes (11). Although it
is clear that the induction of IL-12 and IFN- is essential for
controlling acute infection, the effector cells that are responsible for the control of parasite replication are uncertain.
Macrophages (27, 28) and nonphagocytic cells (29) can be
activated to inhibit or kill the parasites in vitro. Additionally,
both hematopoietic and nonhematopoietic cells must express
IFN- receptors in vivo to adequately control parasite replication (13). However, the relative importance of specific cell
types to the control of infection in vivo remains uncertain.
Extensive focus has been placed on the contributions
made to early responses to T. gondii infection by neutrophils
in the peritoneum (17, 19) and splenic CD8 DCs (20–
22). Both populations produce IL-12 in response to T. gondii
exposure in an MyD88-dependent manner (30, 31), and this
response is thought to be important for the induction of
IFN-, an essential mediator of resistance (12). CCR5
knockout mice develop more severe chronic infections with
T. gondii even though they are not impaired in controlling
acute infections, which suggests that IL-12 induction via
CCR5 positive CD8 DCs is primarily important for controlling the later stages of infection (20).
1765

Previous studies have shown that human and murine
neutrophils produce IL-12 in response to T. gondii (25, 26);
however, this pathway also does not appear to be essential
for the control of acute toxoplasmosis in the mouse model.
Challenging CXCR2/ mice with T. gondii results in more
cysts being present in the brain of chronically infected mice
even though they do not appear to be susceptible to increased mortality during the acute phase (32). It is likely that
this phenotype accurately reflects the role of neutrophils as
CXCR2/ mice suffer an important neutrophil recruitment defect, but maintain the normal recruitment of monocytes (32). Several previous studies have used RB6-8C5
mAb to deplete Gr-1 populations in mice in order to assess
the contribution of neutrophils in host defense against T.
gondii (18, 19, 33). In light of the recent description of Gr-1
monocytes and their capacity to specifically home to sites of
inflammation (3–5), defects that occur after RB6-8C5 mAb
treatment may reflect the combined roles of Gr-1 monocytes and neutrophils.
Importantly, low-dose intraperitoneal infections with nonvirulent strains of T. gondii, a model that simulates dissemination from natural oral infection, fail to recruit substantial numbers of neutrophils or DCs to this site of primary infection
(24). Rather, the primary cell type recruited during this lowdose infection is CD68/Gr-1 monocytes that are capable of
controlling the proliferation of the parasite (24). Our present
study demonstrates that this population of Gr-1 monocytes is
required to control acute toxoplasmosis in the mouse. In the
absence of Gr-1 monocyte recruitment to the site of infection, mice succumbed rapidly to toxoplasmosis characterized
by increased burdens of parasites both locally and, later, systemically. Previous experiments have demonstrated that lethality in the mouse model is related to the rapid attainment of the
high tissue burdens of parasites (34). CD68/Gr-1 monocytes recruited during acute toxoplasmosis also make IL-12
(24); however, this role appears to be secondary as, in their absence, mice develop nearly identical levels of IFN- in the
peritoneum and systemically. Collectively, these findings indicate that Gr-1 monocytes are essential effector cells that act
primarily downstream of IL-12–IFN- induction to control
the initial replication of T. gondii in the mouse model. Because
an absence of MCP-1 or CCR2 has not been found to notably alter the recruitment of neutrophils (4, 8, 9), the susceptibility of MCP-1/ and CCR2/ mice to toxoplasmosis can
be specifically attributed to the recruitment of Gr-1 monocytes. In contrast, the other major subset of murine monocytes
(Gr-1/CCR2/CX3CR1high) has previously been shown
not to play an essential role in the control of toxoplasmosis
based on infections done in CX3CR1/ mice (35).
The substantially higher numbers of parasites present on
day 7 after infection in the peritoneal contents of infected
MCP-1/ and CCR2/ mice compared with wild-type
mice clearly indicate a failure to control early parasite replication at the initial site of infection. The observed differences in
parasite number (7- and 2.5-fold more parasites in
1766

CCR2/ and MCP-1/ mice, respectively, compared
with wild-type mice) are similar to those recently reported
for highly susceptible STAT1/ mice (36). The enhanced
parasite numbers in CCR2/ and MCP-1/ mice also
mimic what is seen with virulent strains of the parasite in
wild-type mice (14). Collectively, these data suggest that the
early control of parasite proliferation is a key determinant of
survival that is provided by Gr-1 monocytes which home to
sites of infection primarily in response to MCP-1. Thus, even
though nonhematopoetic cells are important in controlling
T. gondii replication (13), they are evidently not sufficient to
protect animals against lethal infections in the absence of
Gr-1 monocyte recruitment. This requirement may simply
reflect the efficient toxoplasmicidal responses of Gr-1 monocytes, which are recruited in high numbers, produce nitric
oxide, and are able to inhibit parasite replication (24).
In other infectious challenge models, CCR2/ mice
have demonstrated a delay in the development of the IFN-
responses or an imbalance in Th1 versus Th2 cell responses,
which contribute to the increased susceptibility to Mycobacterium, Leishmania, and Cryptococcus (37–39). In this study, serum IL-12 concentrations in both CCR2/ and MCP-1/
mice were found to lag behind those found in wild-type
mice during the first 7 d after infection (Fig. 6). IL-12 production by macrophages in response to nonvirulent strains of
T. gondii has only recently been appreciated (23), and it is
possible that Gr-1 monocytes also play a role in vivo in the
early induction of IL-12. Although CCR2/ and MCP1/ mice initially produced less IL-12, they developed similar levels of IFN- by day 4 after infection, which indicates
that other cell types are sufficient for the ignition of this essential axis of resistance to T. gondii.
Tip-DCs have previously been shown to play an important role in resistance to Listeria in the mouse model (10).
There are clear phenotypic differences between Tip-DCs and
the inflammatory monocytes described here, despite the fact
that both rely on MCP-1 and CCR2 for trafficking. Notably,
Tip-DCs express DC markers (DEC-205, CD11c) but not
macrophage markers such as F4/80; this is the opposite of the
phenotype of T. gondii–induced inflammatory Gr-1 monocytes described here. The control of listeriosis also critically
depends on TNF- supplied by Tip-DCs (10). In contrast,
TNF- responses were not diminished in CCR2/ mice
challenged with T. gondii; this cytokine is important in resistance to chronic infection but is not essential for the control
of acute toxoplasmosis (40). Nonetheless, the Tip-DCs and
Gr-1 monocytes described here may represent different
manifestations of a common lineage of proinflammatory
monocytes that are capable of differentiating into DCs. Indeed, previous studies have shown that Gr-1 monocytes are
capable of differentiating into DCs in vitro and in vivo (3).
Hence, Gr-1 monocytes may also play a vital role in sampling inflammatory sites before differentiating into DCs and
migrating from periphery to central lymphatic tissues, where
they may also be important in the control of infection.
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Although MCP-1/ mice did not succumb to T. gondii
with the rapidity displayed by CCR2/ mice, their susceptibility to acute toxoplasmosis was considerably enhanced relative to wild-type mice when challenged with higher doses of
T. gondii (Fig. 3). CCR2 is the primary receptor for MCP-1
(41), but mice produce two other known CCR2 ligands, the
monocyte chemotactic proteins MCP-3 and MCP-5 (42,
43), which might serve to partially compensate for the lack of
MCP-1. Consistent with this hypothesis, MCP-1/ mice
were found to recruit fewer Gr-1 monocytes to the peritoneum after i.p. challenge with T. gondii than wild-type mice.
In agreement with such a model, brain tissues from MCP-1/
mice challenged with a normally nonlethal dose of T. gondii
(Fig. 3) were considerably more likely to display severe neuropathology than tissues from chronically infected wild-type
mice. Strikingly, the most severe degree of neuropathology,
marked by the presence of necrotic foci with a gross loss of
brain parenchyma, was never observed in tissues from wildtype mice. Studies of experimental autoimmune encephalomyelitis severity in MCP-1/ have highlighted a critical role
for MCP-1 in the recruitment of macrophages to the tissues
of the central nervous system (CNS; reference 44). By extension, tachyzoites of T. gondii that escape initial control may
disseminate into the CNS and replicate with impunity in the
absence of the MCP-1–mediated recruitment of monocytes.
The infection of human fibroblasts and endothelial cells also
results in the induction of MCP-1 (45), raising the possibility
that the recruitment of inflammatory monocytes is important
in the control of human toxoplasmosis, which frequently involves encephalitis in immunocompromised patients.
The importance of other chemokines and their receptors
for resistance to acute toxoplasmosis has been studied previously by others (46, 47), though these studies focused primarily on the recruitment of T cells. Besides its role in the recruitment of CD8 DCs, CCR5 has been shown to
mediate the recruitment of TGF-–secreting CD8 intraepithelial lymphocytes to sites of intestinal inflammation in mice
orally infected with T. gondii (46). The antibody depletion of
an interferon-induced 10-kD protein (IP-10), a chemoattractant that signals through the chemokine receptor CXCR3
that is expressed on activated Th1 cells, resulted in extreme
susceptibility in mice orally infected with a nonvirulent strain
of T. gondii (47). The depressed recruitment (and subsequent
expansion) of antigen-specific CD8 T cells to the spleen in
antibody-depleted mice was implicated in the failure to control parasite numbers. Because CD8 T cells contribute to
host defense via the production of IFN-, but their cytolytic
capability is less critical (48), it is plausible that the inhibited
recruitment leads to lower systemic levels of IFN-, which
depresses the activity of IFN-–dependent resistance mechanisms. CCR1/ mice fail to control parasite numbers in
many tissues after oral infection with a nonvirulent strain of
T. gondii and rapidly succumb to the infection (49). Notably,
in humans both CCR1 and CXCR2 are expressed on
CD14CD16 monocytes that correspond to the murine
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subset of Gr-1 inflammatory monocytes (3). However,
given the expression of CCR1 on multiple cell types (neutrophils, monocytes, lymphocytes, and eosinophils), CCR1/
mice likely suffer recruitment defects for multiple cell types.
Our studies demonstrate that the successful recruitment of
Gr-1 monocytes via CCR2 and MCP-1 is intimately associated with the ability of mice to resist acute toxoplasmosis.
CCR2/ and MCP-1/ mice displayed defective recruitment of Gr-1 monocytes and failed to control parasite numbers, despite producing normal levels of IFN-. Our findings
on toxoplasmosis, combined with previous studies on other
microorganisms (37–39) argue for a critical role for Gr-1
monocytes as primary effector cells in resistance to pathogens.
MATERIALS AND METHODS
Experimental animals. C57BL/6J and MCP-1/ mice were obtained
from the Jackson Laboratory. CD1 mice were obtained from Charles River
Breeding Laboratories. CCR2/ mice were generated by W.A. Kuziel.
MCP-1/ and CCR2/ mice represent the 10th generation backcrossed
with a C57BL/6 background. Knockout mice were obtained as breeding
pairs, with all subsequent breeding and husbandry of animals undertaken
under specific pathogen-free conditions at the Washington University
School of Medicine. All animal work was conducted in accordance with the
Washington University School of Medicine Animal Studies Committee.
Parasite culture and preparations. Strain PTG (50841; American
Type Culture Collection), a cloned line of the ME49 strain of T. gondii, was
maintained by serial 2-d passage of tachyzoites in human foreskin fibroblast
monolayers as described previously (23). Parasites were routinely tested for
Mycoplasma contamination using a GenProbe kit (Fisher Scientific) and remained negative throughout the experiments.
RNase protection assay of chemokine mRNAs. Total RNA was isolated using TRIzol (Invitrogen). RNase protection assays (BD Biosciences)
were performed with 5 --[32P]UTP (GE Healthcare), according to the kit
manufacturer’s directions, using 15 g of total RNA per sample and an
mCK-5 probe set supplied by the manufacturer. Phosphor imaging and data
analysis of the resulting gels were accomplished using an FLA-5000 phosphor
imager and software supplied by the manufacturer (Fujifilm). For quantification, signal intensity values for individual chemokines were normalized
against the value of a housekeeping gene for the respective treatment group.
Harvest of peritoneal exudates. Immediately after being killed, mice
were peritoneally lavaged with 5 ml of ice-cold HBSS supplemented with 10
mM Hepes and 0.1 mM EGTA. For the recovery of cellular contents, recovered lavage fluid was centrifuged at 200 g for 10 min at 4 C. For the analysis
of chemokine levels in the peritoneum, recovered lavage fluid was centrifuged at 400 g for 10 min at 4 C, and the clarified supernatant stored at
70 C until analyzed by ELISA.
Macrophage culture. Resident peritoneal and thioglycolate-elicited
macrophages were obtained from C57BL/6J mice. Thioglycolate elicitation
was accomplished via i.p. inoculation of 1.5 ml of 3% thioglycolate (Edge
Biologicals) 4 d before harvest. Cells were plated in 96-well plates, 2 105
per well, in DMEM supplemented with 2% FBS. After incubating for 2 h at
37 C, nonadherent cells were removed by washing the wells three times
and replacing the medium with complete DMEM. BMM were obtained as
previously described (23).
ELISA measurement of chemokine levels. MCP-1, TNF-, IL12p70, IFN-, and IL-4 protein concentrations were determined using an
OptEIA kit (BD Biosciences) according to the manufacturer’s directions.
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FACS analysis. After treatment with erythrocyte lysis solution (BD Biosciences) and repeat washing, harvested cells were suspended in staining
buffer (BD Biosciences), seeded in 96-well plates (106 cells/100 l), and
pretreated with BD FcBlock (clone 2.4G2; BD Biosciences) for 10 min at
4 C. Staining with PE conjugated anti-Gr1 (clone RB6-8C5; BD Biosciences) for 1 h at 4 C and washing preceded fixation, permeabilization
(BD Cytofix/Cytoperm; BD Biosciences), and subsequent staining with
FITC conjugated anti-CD68 (clone FA-11; Serotec) for 1 h at 4 C. Cells
(5 104) were analyzed using a FACScan flow cytometer (BD Immunocytometry Systems). Data were analyzed using Cell Quest software (BD Immunocytometry Systems).
Parasite enumeration. Total peritoneal contents were harvested via
peritoneal lavage as described in the Harvest of peritoneal exudates section.
Aliquots of recovered fluid were immediately (without centrifugation) added
to confluent monolayers of human foreskin fibroblast in 96-well culture
plates. Cultures were initiated in quadruplicate with independent serial dilutions performed. After 5–7 d of undisturbed culture, plaques were counted
to determine the initial number of parasites present in the inoculum.

9.

10.

11.

12.

13.

14.
Histopathology. Tissues were fixed in 4% neutral buffered formaldehyde
and embedded in paraffin wax. 5- m sections were hematoxylin and eosin
or periodic acid Schiff stained according to standard procedures.
Statistics. The comparison of means was performed using a one-way
analysis of variance (F-statistic) to establish whether significant differences
were present. Pairwise comparisons between means were performed using
the least significant difference test (based on a Student’s t test), allowing for
the estimation of p-values, when the F-statistic indicated that significant differences existed (50). Analysis of the assignment of neuropathology severity
scores was performed using the nonparametric Mann-Whitney U test using
Minitab v.12.21 software.
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